Extracellular vesicles in allergic rhinitis: Immune regulatory mechanisms and therapeutic applications
World Journal of Stem Cells · 26.06.2026 · 18 (6)
DOI: 10.4252/wjsc.120502 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Stem Cells, online erschienen am 26.06.2026. Verfasst von Hao Fang und 2 weiteren Autor:innen. Die Arbeit nennt 88 Literaturangaben.
Abstract (Originalsprache)
Allergic rhinitis (AR) is a prevalent chronic inflammatory disease worldwide, characterized by Th1/Th2 immune imbalance, nasal mucosal barrier disruption, and complex interactions among various immune cells. Current pharmacological therapies are primarily symptomatic, often failing to correct underlying immune dysregulation and presenting limitations for long-term use. In recent years, extracellular vesicles (EVs), as key mediators of intercellular communication, have demonstrated significant potential in the immune regulation, diagnosis, and treatment of AR. This review systematically highlights the dual role of EVs in AR pathogenesis. On one hand, immune cell-derived EVs can exacerbate Th2-driven immune responses and inflammatory progression by transporting bioactive molecules, such as microRNAs. On the other hand, mesenchymal stem cell-derived EVs demonstrate potent immunomodulatory and tissue-repair capabilities, regulating the activity of dendritic cells, T cells, B cells, and other immune components, restoring Th1/Th2 balance, and repairing the nasal epithelial barrier through the delivery of molecules such as miR-143. Moreover, EVs, along with their associated proteins, microRNAs, and microbiome-derived information, hold promise as biomarkers for AR diagnosis, subtyping, and therapeutic efficacy prediction. Regarding treatment strategies, mesenchymal stem cell-derived EVs can enhance therapeutic outcomes via diverse administration routes and sustained-release hydrogel systems, and may also serve as carriers for antigens or drugs in combination with immunotherapy. Despite their potential, the clinical translation of EVs is confronted with many challenges, e.g., standardization of isolation methods, large-scale production, targeted delivery, and long-term safety. Future research should focus on engineering EVs, elucidating multi-omics mechanisms, and conducting rigorous clinical validation to facilitate their application in clinical practice.
Zitieren
APA
Fang, H., Wang, J., & Li, B. (2026). Extracellular vesicles in allergic rhinitis: Immune regulatory mechanisms and therapeutic applications. World Journal of Stem Cells, 18(6). https://doi.org/10.4252/wjsc.120502
Vancouver
Fang H, Wang J, Li B. Extracellular vesicles in allergic rhinitis: Immune regulatory mechanisms and therapeutic applications. World Journal of Stem Cells. 2026;18(6). doi:10.4252/wjsc.120502
BibTeX
@article{Fang2026,
author = {Fang, Hao and Wang, Jia-Ping and Li, Bing-Bing},
title = {Extracellular vesicles in allergic rhinitis: Immune regulatory mechanisms and therapeutic applications},
journal = {World Journal of Stem Cells},
year = {2026},
volume = {18},
number = {6},
doi = {10.4252/wjsc.120502}
}
EUVIMED